HeartBeam (BEAT) Research & Development (2020 - 2026)

HeartBeam (BEAT) has reported Research & Development for 7 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 30.01% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $11.3 million, a 10.06% decrease from a year earlier, with the FY2025 full-year figure at $13.4 million, up 21.71% from the prior year.
• Research & Development was $2.3 million for Q2 2026 at HeartBeam, down from $2.4 million in the prior quarter.
• Over five years, Research & Development peaked at $3.5 million in Q1 2025 and troughed at $734000.0 in Q1 2022.
• A 5-year average of $2.3 million and a median of $2.3 million in 2026 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 6868.0% in 2022 and sank 32.13% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $1.6 million in 2022, then gained by 22.49% to $2.0 million in 2023, then jumped by 43.58% to $2.9 million in 2024, then climbed by 16.22% to $3.4 million in 2025, then sank by 30.59% to $2.3 million in 2026.
• The last three Research & Development figures came in at $2.3 million (Q2 2026), $2.4 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.